News and views
Our magazine
Insights gives you all the news from the labs, hot topics, health tips and personal stories. Available as a free monthly email or twice-yearly magazine.
Sign up for more news and views
Campaigning
We want men with prostate cancer to get better diagnosis, better treatment and better support. But we can’t do it alone: we need your help.
Join the fightOvercoming the challenges of the pandemic, together.
We've achieved a huge amount for men with prostate cancer throughout the pandemic, thanks to you. We still face huge challenges, but we're more focused on our priorities than ever.
Men, we are with you through Covid19: 7 ways we’re working for men during the pandemic.
Research labs were closed, men had their treatments delayed, and much of our activity grinded to a halt, but prostate cancer didn’t, so neither did we.
Urgent campaign: please take five minutes to tell your MP what prostate cancer research means to you.
We face a cancer crisis following the pandemic. A few minutes of your time could help to protect decades of prostate cancer research.
Abiraterone: hormone therapy for advanced prostate cancer rejected, limiting options for older men.
We condemn the NICE decision to reject abiraterone, limiting options for older men.
#OneCancerVoice: we join charities to call on government to restore cancer services impacted by Covid-19.
Following the coronavirus crisis, there’s danger of a cancer crisis. Today we launch an action plan calling on 10 Downing Street and NHS England to get cancer services back on track.
NHS answers our call: men with newly diagnosed metastatic prostate cancer can access treatment during covid-19 crisis
Thanks to you, treatments that are as effective as chemotherapy are now available for men to take at home.
mpMRI: progress in improving availability of best scans for diagnosis
New data shows more men are getting access to the best scans for diagnosis, but there's more work to do.
Prostate cancer now most commonly diagnosed cancer in England
New data shows prostate cancer is the most common cancer in the UK. Here's why it's not all bad news, and what we do next.
As prostate cancer deaths hit all-time high, we renew our MANifesto
Our response to new data showing prostate cancer deaths hit a record high of 12,000 in one year.
Extra funds for nurse training welcome, but our survey shows workforce under huge strain
The Government's spending review included the promise of funding to train Clinical Nurse Specialists, but more action is needed to address a massively strained workforce.